BR0209361A - Dissódio de pamidronato injetável - Google Patents

Dissódio de pamidronato injetável

Info

Publication number
BR0209361A
BR0209361A BR0209361-8A BR0209361A BR0209361A BR 0209361 A BR0209361 A BR 0209361A BR 0209361 A BR0209361 A BR 0209361A BR 0209361 A BR0209361 A BR 0209361A
Authority
BR
Brazil
Prior art keywords
injectable
pamidronate
pamidronate disodium
alkaline salt
composition
Prior art date
Application number
BR0209361-8A
Other languages
English (en)
Inventor
Dorla Mirejovsky
Jason Edward Brittain
Original Assignee
Sicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sicor Inc filed Critical Sicor Inc
Publication of BR0209361A publication Critical patent/BR0209361A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

"DISSóDIO DE PAMIDRONATO INJETáVEL". A invenção inclui uma composição líquida embalada de um sal alcalino do pamidronato em um recipiente para o armazenamento vedado, que tenha uma superfície interna que não entre em reação com a composição de sal alcalino do pamidronato.
BR0209361-8A 2001-05-02 2002-05-01 Dissódio de pamidronato injetável BR0209361A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28829301P 2001-05-02 2001-05-02
PCT/US2002/013801 WO2002087592A1 (en) 2001-05-02 2002-05-01 Injectable pamidronate disodium

Publications (1)

Publication Number Publication Date
BR0209361A true BR0209361A (pt) 2004-06-08

Family

ID=23106515

Family Applications (1)

Application Number Title Priority Date Filing Date
BR0209361-8A BR0209361A (pt) 2001-05-02 2002-05-01 Dissódio de pamidronato injetável

Country Status (12)

Country Link
US (1) US6709674B2 (pt)
EP (1) EP1390044A4 (pt)
BR (1) BR0209361A (pt)
CA (1) CA2445584A1 (pt)
CZ (1) CZ20032951A3 (pt)
EE (1) EE200300477A (pt)
HU (1) HUP0400087A3 (pt)
MX (1) MXPA03009890A (pt)
PL (1) PL363537A1 (pt)
RU (1) RU2003134700A (pt)
SK (1) SK13522003A3 (pt)
WO (1) WO2002087592A1 (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2406446A1 (en) * 2000-09-18 2002-03-21 Gregory Paul Handreck Diphosphonate solutions
CA2372450A1 (en) * 2001-05-10 2001-09-19 Pharmaceutical Partners Of Canada Inc. Liquid injectable formulation of disodium pamidronate
MY141763A (en) * 2003-09-18 2010-06-30 Novartis Ag Pharmaceutical products comprising bisphosphonates
US20060063720A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Oxaliplatin solution concentrate
US20060063833A1 (en) * 2004-09-22 2006-03-23 Edgar Schridde Ready-to-use oxaliplatin solutions
WO2006100687A1 (en) * 2005-03-24 2006-09-28 Dabur Pharma Ltd. Disodium pamidronate aqueous formulation
WO2011163389A2 (en) * 2010-06-25 2011-12-29 The Trustees Of Columbia University In The City Of New York Method for inducing fat loss in mammals
CN103040766B (zh) * 2013-01-10 2015-09-02 罗诚 一种含有帕米磷酸二钠化合物的药物组合物

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2405254C2 (de) * 1974-02-04 1982-05-27 Henkel KGaA, 4000 Düsseldorf Verwendung von 3-Amino-1-Hydroxypropan-1, 1-diphosphonsäure oder ihrer wasserlöslichen Salze bei der Beeinflußung von Calciumstoffwechselstörungen im menschlichen oder tierischen Körper
US4639338A (en) 1984-08-06 1987-01-27 Ciba-Geigy Corporation Preparation of crystalline disodium 3-amino-1-hydroxypropane-1,1-diphosphonate pentahydrate
US6160165A (en) 1998-12-10 2000-12-12 Aesgen, Inc. Method for preparation of disodium pamidronate
ATE238315T1 (de) * 1998-12-10 2003-05-15 Aesgen Inc Verfahren zur herstellung von dinatriumpamidronat
AUPR018900A0 (en) 2000-09-18 2000-10-12 Fh Faulding Pty Limited Pamidronate solution

Also Published As

Publication number Publication date
EE200300477A (et) 2003-12-15
CZ20032951A3 (cs) 2004-02-18
EP1390044A1 (en) 2004-02-25
WO2002087592A1 (en) 2002-11-07
RU2003134700A (ru) 2005-03-20
HUP0400087A2 (hu) 2004-04-28
SK13522003A3 (sk) 2004-04-06
PL363537A1 (en) 2004-11-29
EP1390044A4 (en) 2005-03-23
US6709674B2 (en) 2004-03-23
MXPA03009890A (es) 2004-02-17
HUP0400087A3 (en) 2007-05-29
CA2445584A1 (en) 2002-11-07
US20030069211A1 (en) 2003-04-10

Similar Documents

Publication Publication Date Title
ATE424117T1 (de) Calciumhaltiger kaugummi mit mittiger füllung
WO2005089954A3 (en) Unit dose delivery system for two-component composition
AR011714A1 (es) Conjunto de envasado y de aplicacion de un producto liquido
ES2114487B1 (es) Mezcla estabilizante sinergistica.
ES2166137T3 (es) Embalaje dotado de un cupon y procedimiento de obtencion de dicho embalaje.
BR0208060A (pt) Bolsa flexìvel com múltiplos compartimentos
ES2193578T3 (es) Complejos de calcio para el enriquecimiento de alimentos.
MX171722B (es) Recipiente distribuidor de substancia viscosa
AR034736A1 (es) Sistema de emanacion de liquido a base de mecha
AR032705A1 (es) Recipiente flexible que tiene pico resellable formado integralmente
DE60322098D1 (de) Behälteranordnungssystem mit mehreren fächern
BR0209361A (pt) Dissódio de pamidronato injetável
BR0116136B1 (pt) embalagem comercial que compreende uma composição de branqueamento junto com as instruções para seu uso.
AR029254A1 (es) Un sistema de envase y un cierre que comprende dicho envase
MXPA03008794A (es) Mejoras en o relacionadas con dispositivos refrescantes de aire.
BR9905339A (pt) Recipiente com elemento de retenção
DE60003943D1 (de) Trimegestone enthaltende pharmazeutische zusammensetzungen
DE60306137D1 (de) Verpackung für zigaretten
AR038215A1 (es) Raticida envasado
AR040015A1 (es) Miniesferas de alumbre
UY27932A1 (es) Tapa y recipiente contenedor de productos
CO5580729A2 (es) Composiciones nutricionales que comprenden cistationina
BRPI0504830A (pt) sistema de trava para refil, embalagem que compreende o dito sistema de trava e refil
SV2006002222A (es) Desoxidacion de polvos de metales rectificadores ref. sta 00233-sv
BRPI0408195A (pt) embalagens solúveis em água contendo composições lìquidas

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A(S) 7A,8A E 9A ANUIDADE(S)

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2103 DE 26/04/2011.